Anzeige
Mehr »
Dienstag, 14.07.2026 - Börsentäglich über 12.000 News
Time to Buy! Diese drei Kräfte treiben die Tiefsee-Exploration massiv an
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
507 Leser
Artikel bewerten:
(2)

Poultry Diagnostics Market worth $0.25 billion by 2031 | MarketsandMarkets

DELRAY BEACH, Fla., March 19, 2026 /PRNewswire/ -- According to MarketsandMarkets, the Poultry Diagnostics Market is projected to grow from about USD 0.18 billion in 2026 to USD 0.25 billion by 2031, at a CAGR of 7.1%.

Browse 480 market data Tables and 65 Figures spread through 500 Pages and in-depth TOC on 'Poultry Diagnostics Market - Global Forecast to 2031'

Poultry Diagnostics Market Size & Forecast:

  • Market Size Available for Years: 2025-2031
  • 2026 Market Size: USD 0.18 billion
  • 2031 Projected Market Size: USD 0.25 billion
  • CAGR (2026-2031): 7.1%

Poultry Diagnostics Market Trends & Insights:

  • By product type, the consumables & reagents segment is expected to register the highest CAGR of 7.5%.
  • By test type, the PCR-based diagnostics segment is expected to dominate the market with a share of 47.1% in 2025.
  • By poultry type, the broilers segment in the PCR-based diagnostics market accounted for the largest share of 42.5% in 2025.
  • The Asia Pacific poultry diagnostics market is estimated to register the highest CAGR of 8.6% during the forecast period.

Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134560458

The poultry diagnostics market is experiencing gradual growth due to the continuous introduction of new products and the increasing demand for enhanced disease detection and surveillance. Innovative techniques such as real-time PCR, multiplex assays, high-throughput automated ELISA systems, and portable point-of-care testing platforms provide faster, more sensitive, and accurate pathogen identification. Advances in primer and probe design, improved reagents, and assay optimizations are making diagnostics for avian influenza, Newcastle disease, and other rapidly mutating pathogens more reliable.

A significant driver of growth in the poultry diagnostics market is product-level innovation. For example, leading veterinary diagnostic companies have developed next-generation multiplex real-time PCR kits. These kits can simultaneously detect multiple avian pathogens, including avian influenza, Newcastle disease, and infectious bronchitis, within a single test run. The test formats combine higher sensitivity, better strain coverage, and shorter turnaround times, while remaining compatible with the most widely used laboratory PCR platforms.

The industry trend is toward simplified workflows, ready-to-use reagents, and improved assay stability, resulting in procedure-specific, user-friendly diagnostic solutions. This ensures consistent, reliable results not only during routine monitoring but also in emergency disease control programs.

By test type, the PCR-based diagnostics segment accounted for the largest market share in 2025.

In the poultry diagnostics market, the PCR-based diagnostics segment held the largest market share in 2025. This dominance is primarily due to their ability to detect pathogens at early stages of infection with greater sensitivity and accuracy compared to other methods. Real-time PCR enables rapid and precise detection of major diseases such as avian influenza, Newcastle disease, and Mycoplasma infections, making it crucial for outbreak control and regulatory surveillance. Additionally, this method's compatibility with multiplex testing and ease of integration into high-throughput laboratory workflows have led to its widespread acceptance in veterinary diagnostic laboratories and government monitoring programs.

Request Sample Pages@https://www.marketsandmarkets.com/requestsampleNew.asp?id=134560458

By poultry type, the broilers segment is expected to grow at the highest CAGR during the forecast period.

The broilers segment is anticipated to experience the highest CAGR during the forecast period. This is largely due to its dominance in global poultry meat production and the short production cycles that make broilers more susceptible to rapid disease spread. To prevent large-scale disease outbreaks, it is crucial that commercial broiler farms, which often operate at high stocking densities, conduct regular health monitoring and routine diagnostic testing. Additionally, the cultivation of broilers for export and the enforcement of strict biosecurity measures are driving the adoption of advanced diagnostic solutions in this segment.

North America accounted for the largest share of the market in 2025.

In 2025, North America represented the largest share of the poultry diagnostics market. This is primarily due to the region's extensive commercial poultry industry, well-developed veterinary laboratory infrastructure, and strict regulatory surveillance programs. North America also has a high adoption rate of PCR-based and automated diagnostic technologies, which are further supported by the government's robust disease monitoring initiatives, including those for avian influenza. Additionally, the presence of leading diagnostic manufacturers and stringent biosecurity and export regulations contributes to the considerable volume of testing conducted in the region.

Inquire Before Buying@https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=134560458

Top Companies in Poultry Diagnostics Market:

The Top Companies in Poultry Diagnostics Market include IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), BioNote (South Korea), Innovative Diagnostics (France), Bio-Rad Laboratories, Inc. (US), BioChek (Netherlands), GD (Netherlands), INDICAL BIOSCIENCE GmbH (Germany), Shenzhen Bioeasy Biotechnology, Inc. (China), Ring Biotechnology Co., Ltd. (China), Bio-X Diagnostics S.A. (Belgium), MEGACOR Diagnostik GmbH (Austria), Gold Standard Diagnostics (Germany), and Bioneer Corporation (South Korea). These companies are recognized leaders in the field of poultry diagnostics.

Browse Adjacent Markets: Medical Devices Market Research Reports & Consulting

Related Reports:

Veterinary Vaccines Market - Global Forecast to 2030

Veterinary Diagnostics Market - Global Forecast to 2030

Veterinary Equipment and Supplies Market - Global Forecast to 2030

Veterinary Imaging Market - Global Forecast to 2031

Veterinary Ultrasound Market - Global Forecast to 2031

About MarketsandMarkets

MarketsandMarkets has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets.com or follow us on Twitter , LinkedIn and Facebook .

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/

Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/poultry-diagnostics-market-worth-0-25-billion-by-2031--marketsandmarkets-302718565.html

© 2026 PR Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.